Company Profile
Rinri Therapeutics Limited
11680455•Private Limited With Share Capital
Get Full Access
15/11/2018
7 years
6
14
72110
low risk
Company Overview
Registration, classification & business activity
Rinri Therapeutics Limited (11680455) is a private limited with share capital incorporated on 15/11/2018 (7 years old) and registered in sheffield, S14DP. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Rinri therapeutics is a private biotechnology company developing first-in-class cell therapies to restore hearing. hearing loss affects over 400m people in the world; 90% caused by sensorineural hearing loss (snhl). there are currently no disease-modifying therapeutics for snhl patients. rinri's pio...
Financial Overview
£5.26M
£21.17M
£-15.92M
£3.86M
£3.70M
Key Metrics
14
Employees
6
Directors
8
Shareholders
2
Patents
Board of Directors
Innovate Grants
This company received a grant of £1618080.1 for Preclinical Development Of A First In Class Stem Cell Therapy For Hearing Loss. The project started on 01/04/2021 and ended on 31/05/2023.
This company received a grant of £41963.0 for End-User Testing Of A Novel Perfusion Bioreactor For Scalable Biomanufacturing Of Cell Therapies. The project started on 01/08/2025 and ended on 30/09/2025.
Import / Export
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating